Patient Profiles

General Conditions of Use
Privacy Statement
Report a Side Effect

General Conditions of Use
Privacy Statement
Report a Side Effect

Country select
- Gemany
- Japan
- United States

Switch Language

English
Français

General Conditions of Use
Privacy Statement
Report a Side Effect

Switch Language

English
Français

Hemophilia Hub Hemophilia Hub

Products
- JIVI^®
- KOVALTRY^®
Tools & Resources
- Download Resource Centre
- myWAPPS
JIVI^® Safety Information
KOVALTRY^® Safety Information

Products
- JIVI^®
- KOVALTRY^®
Tools & Resources
- Download Resource Centre
- myWAPPS
JIVI^® Safety Information
KOVALTRY^® Safety Information

General Conditions of Use
Privacy Statement
Report a Side Effect

Country select
- Gemany
- Japan
- United States

Switch Language

English
Français

General Conditions of Use
Privacy Statement
Report a Side Effect

Who are your potential Jivi patients?

Breadcrumb

Home
Products
JIVI^®
Jivi® Patient Profiles

Please refer to the dosing section on this website for more information on Jivi's dosing.

ABR=annualized bleed rate.
* Fictitious patient. Individual results may vary.

Footer Block

General Conditions of Use
Privacy Statement
Imprint

The information on this site is intended for Canadian residents only.
Last Updated: August, 2024

PP-JIV-CA-0139-4

Accessibility

Imprint

hidden link for autofocus

hidden link for autofocus

Imprint

Published by:

Bayer Inc., Canada

Represented by Corporate Communications:

2920 Matheson Boulevard East

Mississauga, Ontario L4W 5R6

Email: contactbayer@bayer.com

hidden link for autofocus

Ressources supplémentaires

Soutien professionnel

Centres d’excellence académique

Soutien pour la recherche, la formation, les ressources cliniques, l’éducation et le transfert des connaissances.

Soutien aux patients

Outils et services pour les patients

Ressources éducatives sans marque

Les adultes et les adolescents (âgés d’au moins 12 ans) atteints d’hémophilie A à qui l’on a prescrit Jivi^® pour une indication autorisée par Santé Canada peuvent s’inscrire au programme de soutien aux patients et au Programme de fournitures pour perfusion à domicile KoKonnect^MC.

- Le programme de soutien aux patients KoKonnect^MC fournit du soutien par des membres du personnel infirmier et des services de formation pour vous aider avec vos perfusions de Jivi^®.

- Le Programme de fournitures pour perfusion à domicile KoKonnect^MC fournit les fournitures pour perfusion (tampons alcoolisés, cotons et pansements) nécessaires pour vos perfusions de Jivi^®.

Demandez aux professionnels de la santé de votre centre de traitement de l’hémophilie si vous avez besoin d’accéder au programme de soutien aux patients ou au Programme de fournitures pour perfusion à domicile KoKonnect^MC.

hidden link for autofocus

Additional resources

Professional support

Projects of Excellence

The Projects of Excellence program aims to provide sponsorship for projects that will create evidence-based tools or education material for hemophilia A, provide insights on the management of hemophilia A, and improve the quality of life for Canadians living with hemophilia A.

Patient Support Program

Hemophilia A patients who have been prescribed Jivi or Kovaltry for an authorized indication are eligible to enroll in the KoKonnect™ Patient Support Program and the KoKonnect™ Home Infusion Supplies Patient Support Program.

- The KoKonnect™ Patient Support Program provides nursing support and training services to assist patients with their Jivi^® or Kovaltry^® infusions.

- The KoKonnect™ Home Infusion Supplies Patient Support Program provides infusion supplies (alcohol swabs, dry pads, bandages) that are required for patients’ Jivi or Kovaltry infusions.

If you require more information on the KoKonnect™ Patient Support Program, please contact your Bayer Representative.

hidden link for autofocus

Healthcare Professionals

Enter your license number to learn more about Bayer hemophilia products.

How do I get a license number?

Because this website is only intended for Canadian healthcare professionals, you must use a valid Canadian license number to enter the site.

hidden link for autofocus

Patients

Enter the DIN number located on the packaging provided by your healthcare professional to access the site.

Where can I find my DIN number?

Because this website is only intended for Canadian patients who are prescribed Bayer products, you must enter the DIN number to enter the site. Your doctor, nurse or hemophilia treatment centre (HTC) can provide you with this code.

hidden link for autofocus

To report a side effect or quality complaint, please contact Bayer Medical Information at https://safetrack-public.bayer.com/ or by calling 1-800-265-7382, between the hours of 7:30 am and 7:30 pm, EST.

You can report any suspected side effects associated with the use of health products to Health Canada by:

Visiting the Web page on Adverse Reaction Reporting http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.php for information on how to report online, by mail or by fax; or
Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Who are your potential Jivi patients?

Footer Block

Imprint

Ressources supplémentaires

Soutien professionnel

Centres d’excellence académique

Soutien aux patients

Outils et services pour les patients

Ressources éducatives sans marque

Additional resources

Professional support

Projects of Excellence

Patient Support Program

Healthcare Professionals Enter your license number to learn more about Bayer hemophilia products.

Patients Enter the DIN number located on the packaging provided by your healthcare professional to access the site.

Healthcare Professionals

Enter your license number to learn more about Bayer hemophilia products.

Patients

Enter the DIN number located on the packaging provided by your healthcare professional to access the site.